NCT06874946
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Clinical trial condition
PTCL
Explore clinical trials studying PTCL. Study availability and eligibility vary by location and protocol.
12 public trials
3 recruiting studies
PTCL trial results
Recruiting
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
NCT04747236
- Conditions
- PTCL
- Locations
-
- VA Long Beach Health Care System Long Beach, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- Duke University Durham, North Carolina, United States
Recruiting
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
NCT05967949
- Conditions
- PTCL
- Locations
-
- Hematological Department, People's Hospital of Jiangsu Province Nanjing, Jiangsu, China
Not Yet Recruiting
SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)
NCT07725705
- Conditions
- First Line Treatment, PTCL
- Locations
-
Not specified
Not Yet Recruiting
A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.
NCT07657572
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
Not specified
Not Yet Recruiting
TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma
NCT07639879
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +5 more
- Locations
-
- Peking University Cancer Hospital Beijin, Beijing Municipality, China
Not Yet Recruiting
Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL
NCT07493330
- Conditions
- PTCL, Refractory
- Locations
-
Not specified
Not Yet Recruiting
SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma
NCT07347288
- Conditions
- PTCL
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Completed
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
NCT03900442
- Conditions
- Advanced Cancer, PTCL
- Locations
-
- Epworth Healthcare Melbourne, Victoria, Australia
Completed
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
NCT03493451
- Conditions
- ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
- Locations
-
- British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China